BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34153138)

  • 1. A Functional Variant on 9p21.3 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B-AS1.
    Ali MW; Patro CPK; Devall M; Dampier CH; Plummer SJ; Kuscu C; Adli M; Lai RK; Casey G
    Hum Mutat; 2021 Oct; 42(10):1208-1214. PubMed ID: 34153138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes.
    Ali MW; Patro CPK; Zhu JJ; Dampier CH; Plummer SJ; Kuscu C; Adli M; Lau C; Lai RK; Casey G
    Hum Mutat; 2021 Jan; 42(1):77-88. PubMed ID: 33169458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-ancestry genome-wide association study of 4069 children with glioma identifies 9p21.3 risk locus.
    Foss-Skiftesvik J; Li S; Rosenbaum A; Hagen CM; Stoltze UK; Ljungqvist S; Hjalmars U; Schmiegelow K; Morimoto L; de Smith AJ; Mathiasen R; Metayer C; Hougaard D; Melin B; Walsh KM; Bybjerg-Grauholm J; Dahlin AM; Wiemels JL
    Neuro Oncol; 2023 Sep; 25(9):1709-1720. PubMed ID: 36810956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a Chromosome Locus 9p21.3 CDKN2B-AS1 Variant rs4977574 with Hypertension: The TAMRISK Study.
    Kunnas T; Piesanen J; Nikkari ST
    Genet Test Mol Biomarkers; 2018 May; 22(5):327-330. PubMed ID: 29791233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients.
    Bayoglu B; Yuksel H; Cakmak HA; Dirican A; Cengiz M
    Clin Biochem; 2016 Jul; 49(10-11):821-7. PubMed ID: 26944720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
    Harismendy O; Notani D; Song X; Rahim NG; Tanasa B; Heintzman N; Ren B; Fu XD; Topol EJ; Rosenfeld MG; Frazer KA
    Nature; 2011 Feb; 470(7333):264-8. PubMed ID: 21307941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer-promoter interaction.
    Wang H; Yang B; Cai X; Cheng X; Shen N; Liu L; Li J; Wang Y; He H; Ying P; Li B; Lu Z; Yang N; Wang X; Zhang F; Li Y; Wang W; Ning C; Zhu Y; Chang J; Miao X; Tian J; Zhong R
    Carcinogenesis; 2021 Nov; 42(11):1347-1356. PubMed ID: 34665859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between Established Glioma Risk Variants and DNA Methylation in the Tumor.
    Dahlin AM; Wibom C; Ghasimi S; Brännström T; Andersson U; Melin B
    PLoS One; 2016; 11(10):e0163067. PubMed ID: 27780202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma.
    Wang TM; Xiao RW; He YQ; Zhang WL; Diao H; Tang M; Mai ZM; Xue WQ; Yang DW; Deng CM; Liao Y; Zhou T; Li DH; Wu YX; Chen XY; Zhang J; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Cai Y; Zheng Y; Zhang Z; Zhou Y; Jin G; Bei J; Mai HQ; Sun Y; Ma J; Hu Z; Liu J; Lung ML; Adami HO; Ye W; Lam TH; Shen H; Jia WH
    Am J Hum Genet; 2023 Jul; 110(7):1162-1176. PubMed ID: 37352861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Variants in the 9p21.3 Locus Associated with Glioma Risk in Children, Adolescents, and Young Adults: A Case-Control Study.
    Dahlin AM; Wibom C; Andersson U; Hougaard DM; Bybjerg-Grauholm J; Deltour I; Hultman CM; Kähler AK; Karlsson R; Hjalmars U; Melin B
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1252-1258. PubMed ID: 31040135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
    Thakur N; Kupani M; Mannan R; Pruthi A; Mehrotra S
    BMC Med Genomics; 2021 Jan; 14(1):1. PubMed ID: 33397358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility.
    Baskin R; Woods NT; Mendoza-Fandiño G; Forsyth P; Egan KM; Monteiro AN
    Sci Rep; 2015 Nov; 5():17367. PubMed ID: 26610392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.
    Youn BJ; Cheong HS; Namgoong S; Kim LH; Baek IK; Kim JH; Yoon SJ; Kim EH; Kim SH; Chang JH; Kim SH; Shin HD
    Mol Biol Rep; 2022 Nov; 49(11):10339-10346. PubMed ID: 36097105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (
    Yuan W; Zhang W; Zhang W; Ruan ZB; Zhu L; Liu Y; Mi YY; Zhang LF
    Bioengineered; 2020 Dec; 11(1):1084-1098. PubMed ID: 33054494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the functional role of polymorphism in the CDKN2B-AS1 gene GWAS-significant for primary open-angle glaucoma (an in-silico study)].
    Eliseeva NV; Ponomarenko IV; Churnosov MI
    Vestn Oftalmol; 2021; 137(4):43-50. PubMed ID: 34410056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk.
    Giaccherini M; Farinella R; Gentiluomo M; Mohelnikova-Duchonova B; Kauffmann EF; Palmeri M; Uzunoglu F; Soucek P; Petrauskas D; Cavestro GM; Zykus R; Carrara S; Pezzilli R; Puzzono M; Szentesi A; Neoptolemos J; Archibugi L; Palmieri O; Milanetto AC; Capurso G; van Eijck CHJ; Stocker H; Lawlor RT; Vodicka P; Lovecek M; Izbicki JR; Perri F; Kupcinskaite-Noreikiene R; Götz M; Kupcinskas J; Hussein T; Hegyi P; Busch OR; Hackert T; Mambrini A; Brenner H; Lucchesi M; Basso D; Tavano F; Schöttker B; Vanella G; Bunduc S; Petrányi Á; Landi S; Morelli L; Canzian F; Campa D
    Int J Cancer; 2023 Jul; 153(2):373-379. PubMed ID: 36451333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of SNPs in LncRNA CDKN2B-AS1 with breast cancer susceptibility in Chinese Han population.
    Sun Q; Chong F; Jiang X; Wang Y; Xu K; Zou Y; Song C
    Int J Biochem Cell Biol; 2022 Feb; 143():106139. PubMed ID: 34954153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of CAV1/CAV2 rs4236601 and CDKN2B-AS1 rs2157719 in primary open-angle glaucoma patients from Brazil.
    Nunes HF; Ananina G; Costa VP; Zanchin NIT; de Vasconcellos JPC; de Melo MB
    Ophthalmic Genet; 2018 Apr; 39(2):194-199. PubMed ID: 29111846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic Imbalance in Regulation of ANRIL through Chromatin Interaction at 9p21 Endometriosis Risk Locus.
    Nakaoka H; Gurumurthy A; Hayano T; Ahmadloo S; Omer WH; Yoshihara K; Yamamoto A; Kurose K; Enomoto T; Akira S; Hosomichi K; Inoue I
    PLoS Genet; 2016 Apr; 12(4):e1005893. PubMed ID: 27055116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CDKN2A/CDKN2B with inflammatory bowel disease in Koreans.
    Lee HS; Lee SB; Kim BM; Hong M; Jung S; Hong J; Baek J; Han B; Oh SH; Kim KM; Park SH; Yang SK; Ye BD; Song K
    J Gastroenterol Hepatol; 2018 Apr; 33(4):887-893. PubMed ID: 29063720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.